$1 Billion         |         Rank #2578

Who is Jean-Paul Clozel

The husband-and-wife team sold the company to Johnson & Johnson for $30 billion in 2017.
Actelion makes drugs for orphan diseases, which affect fewer than 200,000 people
and typically receive little research funding.

Following the Johnson & Johnson acquisition, the couple spun out publicly-traded Idorsia, which they now run together.
Idorsia is specializing in the discovery and development of small molecules to eventually develop drugs to treat insomnia, lupus and other diseases. Coming from an average or middle class family, Jean-Paul Clozel is one those great persons who have stormed their way to the billionaires list on their own. And currently ranks at 2578 on billionaires list making him one of the wealthiest ever persons on the planet. He is currently 67.0 years old. As of today, Jean-Paul Clozel’s net worth is approximately 1 Billion.

Facts about Jean-Paul Clozel

To find out what is Jean-Paul Clozel Net Worth, how he got there and what is Jean-Paul Clozel Salary Per Day, Career, Biography and Childhood details, continue reading below.

Background of Jean-Paul Clozel

Jean-Paul Clozel was born on 03-04-55 in Switzerland. Jean-Paul is a trained cardiologist and Martine is a trained pediatrician. To start Actelion, the Clozels reportedly sold their house and worked out of a rented garage in the company’s early days. Being raised in the same country, Jean-Paul Clozel spent most of his time in nan in the city of Basel.

Jean-Paul Clozel net worth is estimated at 1 Billion Billion to date.

Professional Journey

You will see him often in social media.  Jean-Paul Clozel and his wife Martine Clozel cofounded Swiss biotech firm Actelion in 1997 with three other colleagues. There was a time when he would have embraced the change that was coming.  He is one of the persons who are always trending in news. Jean-Paul is a trained cardiologist and Martine is a trained pediatrician. In his youth, he was adventurous but unknown, but that was years ago. The husband-and-wife team sold the company to Johnson & Johnson for $30 billion in 2017.
Actelion makes drugs for orphan diseases, which affect fewer than 200,000 people
and typically receive little research funding.

Following the Johnson & Johnson acquisition, the couple spun out publicly-traded Idorsia, which they now run together.
Idorsia is specializing in the discovery and development of small molecules to eventually develop drugs to treat insomnia, lupus and other diseases. He learnt to find the excitement that came with change. That curiosity had long left him to where he had come to loathe anything that put him out of his comfort zone. Jean-Paul Clozel and his wife Martine Clozel cofounded Swiss biotech firm Actelion in 1997 with three other colleagues.
It is to be noted that Jean-Paul Clozel is one of the selfmade billionaires in the world and stands at 2578 in most wealthy persons in the world.

FAQs

Here are a few most frequently asked questions about Jean-Paul Clozel:

How much is Jean-Paul Clozel worth?

Jean-Paul Clozel’s net worth is estimated to be 1 Billion.

How old is Jean-Paul Clozel?

Jean-Paul Clozel was born on 03-04-55, and is currently 67.0 years old.

What is Jean-Paul Clozel source of income?

Jean-Paul Clozel acquires most part of his wealth from pharmaceuticals.
 

Concluding Jean-Paul Clozel Net Worth

Currently with a net worth of 1 Billion, Jean-Paul Clozel stands at 2578 in the world billionaires list. And draws most of his wealth from pharmaceuticals. Hope you like this information about Jean-Paul Clozel. If you like this, then please share it with your friends. This above post is all about the estimated worth of Jean-Paul Clozel. Do you have any queries? Feel free to ask via comment section.

Disclaimer: Please keep in mind that this is an estimated net worth of Jean-Paul Clozel. Actual worth may vary a little. You can always get information by checking out Leaktown.com.